Cabaletta Bio (CABA) Shareholder's Equity Growth (3y) (2021 - 2025)
Cabaletta Bio (CABA) Shareholder's Equity Growth (3y) (2021 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Cabaletta Bio |
151.84 Mn |
18.24 Mn |
- |
| Date | Value |
|---|
| Dec 31, 2025 |
2.35% |
| Sep 30, 2025 |
17.54% |
| Jun 30, 2025 |
23.16% |
| Mar 31, 2025 |
4.43% |
| Dec 31, 2024 |
8.90% |
| Sep 30, 2024 |
14.32% |
| Jun 30, 2024 |
25.34% |
| Mar 31, 2024 |
28.99% |
| Dec 31, 2023 |
29.19% |
| Sep 30, 2023 |
11.05% |
| Jun 30, 2023 |
11.79% |
| Mar 31, 2023 |
-11.38% |
| Dec 31, 2022 |
-8.92% |
| Sep 30, 2022 |
74.28% |
| Jun 30, 2022 |
85.12% |
| Mar 31, 2022 |
96.62% |
| Dec 31, 2021 |
135.34% |
| Sep 30, 2021 |
137.58% |
